Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |